Study of REKOVELLE for first-time IVF or ICSI in Chinese women
Part of Women’s health & pregnancy clinical trials.
This study looks at how well the medication REKOVELLE works for Chinese women going through their first IVF or ICSI cycle. It will track real-world results, safety, and how the medication is used. It may help if you are starting IVF or ICSI for the first time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman at least 20 years old.
- Your doctor has prescribed REKOVELLE for your first IVF or ICSI treatment cycle.
- You have not had more than one ovarian stimulation cycle for IVF or ICSI before.
- You are not currently in another study that requires you to take a medication.
- You are not using ovarian stimulation for fertility preservation or egg donation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This survey collects information from people who have already used REKOVELLE (a medication that helps the ovaries produce eggs) as part of their fertility treatment. Taking part will help researchers learn how the medication works in real-world daily practice.
This trial tests a fixed dose of the hormone follitropin delta (Rekovelle) to stimulate the ovaries before intrauterine insemination (IUI). It aims to see if this approach works well for women with regular cycles who are starting IUI for the first time.
This trial compares a generic version of cetrorelix acetate (a medication used to control ovulation) to the brand-name version during IVF. It aims to see if the generic works just as well for women undergoing ovarian stimulation.
This trial tests a fertility injection called Corifollitropin alfa to help women aged 36–40 produce eggs for in-vitro fertilization (IVF). Researchers want to confirm it is safe and effective in this age group using a specific ovarian stimulation protocol.
This study looks at how follitropin delta is used in real clinics to help women stimulate eggs for IVF or ICSI. It may help doctors fine-tune dosing by comparing outcomes in everyday practice.
This trial tests a treatment for women with infertility caused by ovulation problems, like PCOS or low ovarian reserve, or when IVF is needed due to a male factor. It aims to see if a Chinese medicine approach can help improve IVF success.
Hear when a new Infertility trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.